Levamisole in dermatology: A review

American Journal of Clinical Dermatology

Volumn 5, Issue 2, 2004, Pages 97-104

  Scheinfeld, Noah ^a   Rosenberg, Joshua D ^a   Weinberg, Jeffrey M ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTHELMINTIC AGENT; ANTIINFECTIVE AGENT; CIMETIDINE; CLOBETASONE; CLOFAZIMINE; DAPSONE; FLUOCINOLONE; FLUOROURACIL; GOLD; INDOMETACIN; LEPROSTATIC AGENT; LEVAMISOLE; LUPUS ANTICOAGULANT; PENICILLAMINE; PREDNISOLONE; STIBOGLUCONATE SODIUM; ZINC;

ABDOMINAL CRAMP; ALOPECIA; ARTHRALGIA; BACTERIAL INFECTION; BURN; CLINICAL TRIAL; COLON CANCER; DRUG ERUPTION; FLU LIKE SYNDROME; HUMAN; IMMUNE FUNCTION TEST; IMMUNOMODULATION; INFECTION; INFESTATION; LEG ULCER; LEPROSY; LEUKOPENIA; LICHEN PLANUS; LICHENOID; LIVER TOXICITY; NAUSEA; NECROTIZING ARTERITIS; NEPHROTOXICITY; PARASITOSIS; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; SKIN DISEASE; SKIN NECROSIS; VASCULAR DISEASE; VIRUS INFECTION;

ADJUVANTS, IMMUNOLOGIC; HUMANS; LEVAMISOLE; RANDOMIZED CONTROLLED TRIALS; SKIN DISEASES;

EID: 2442480614     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200405020-00004     Document Type: Review

References (124)

1. Assem ESK. Textbook of immunopharmacology. Dale MM, Foreman JC, editors. London: Blackwell Science Publications, 1984: 333-9
2. Gennaro AR. Remington: the science and practice of pharmacy. 19th ed. Easton (PA): Mack Publishing Co., 1995: 101-2
3. Hadden JW. T-cell adjuvants. Int J Immunopharmacol 1994; 16: 703-10
4. Szeto C, Gillespie KM, Mathieson PW. Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance. Immunology 2000; 100: 217-24
5. Renoux G. The general immunopharmacology of levamisole. Drugs 1980; 19: 89-99
6. Sun A, Chiang CP. Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus. J Oral Pathol Med 2001; 30: 542-8
7. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8
8. Alsaran K, Grisaru S, Stephens D, et al. Levamisole vs cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome. Clin Nephrol 2001; 56: 289-94
9. Renoux G. Modulation of immunity by levamisole. J Pharmacol Ther 1978; 2: 288-96
10. Sweetman SC. Martindale: the complete drug reference. 33rd ed. Chicago (IL): Pharmaceutical Press, 2002: 1253-4
11. Roberts G. Levamisole. IPCS INCHEM Canada [online]. Available from URL: http://www.inchem.org/documents/jecfa/jecmono/v33je02.htm [Accessed 2004 Mar 19]
12. Symoens J, Veys E, Mielants M, et al. Adverse reactions to levamisole. Cancer Treat Rep 1978; 62: 1721-30
13. Hook CC, Kimmel DW, Kvols LK, et al. Mutlifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Ann Neurol 1992; 31: 262-7
14. Kimmel DW, Schutt AJ. Mutlifocal leukoencephalopathy: occurrence during 5-fluorouracil and levamisole therapy and resolution after discontinuation of chemotherapy. Mayo Clin Proc 1993; 68: 363-5
15. Lucia P, Pocek M, Passacantando A, et al. Multifocal leukoencephalopathy induced by levamisole [letter]. Lancet 1996; 348: 1450
16. Secher L, Permin H, Skov PS, et al. Levamisole-induced hypersensitivity. Acta Derm Venereol 1978; 58: 372-4
17. Kirby JD, Black M, McGibbon D. Levamisole-induced lichenoid eruptions. J R Soc Med 1980; 73: 208-11
18. Clavere P, Bonnafoux-Clavere A, Delrous JL, et al. Fixed pigmented erythema caused by levamisole administration. Ann Dermatol Venereol 1994; 121: 238-9
19. Fellner MJ, Ledesma GN. Leg ulcers secondary to drug reactions. Clin Dermatol 1990; 8: 144-9
20. Scheinberg MA, Bezerra JB, Almeida FA, et al. Cutaneous necrotising vasculitis induced by levamisole [letter]. BMJ 1978; 18: 408
21. Powell J, Grech H, Holder J. A boy with cutaneous necrosis occurring during treatment with levamisole. Clin Exp Dermatol 2002; 27: 32-3
22. Rongioletti F, Ohio L, Ginevri F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999; 140: 948-51
23. Menni S, Pistritto G, Gianotti R, et al. Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 1997; 14: 477-9
24. Papageorgiou P, Kesarwala HH, Alcid DV, et al. Levamisole in chronic pyoderma. J Clin Lab Immunol 1982; 8: 121-7
25. Djawari D, Homstein OP. Recurrent chronic pyoderma with cellular immunodeficiency: successful therapy by levamisole. Dermatologica 1980; 161: 116-23
26. Svejgaard E, Christiansen AH, Stahl D, et al. Clinical and immunological studies in chronic dermatophytosis caused by Trichophyton rubrum. Acta Derm Venereol 1984; 64: 493-500
27. Butler PG. Levamisole therapy of chronic Leishmania tropica. J Trop Med Hyg 1978; 81: 221-4
28. Paul Y, Singh J. Cutaneous larva migrans in an infant. Indian Pediatr 1994; 31: 1089-91
29. Namazi MR. Levamisole: a safe and economical weapon against pediculosis. Int J Dermatol 2001; 40: 292-4
30. Raptopoulou GM, Kountouras J, Goulis G. Levamisole in the treatment of chronic brucellosis. J Immunopharmacol 1980; 2: 85-97
31. Haneke E. Levamisole therapy under different dermatological indications. Z Hautkr 1979; 54: 408-14
32. Russell AS, Brisson E, Grace M. A double-blind controlled trial of levamisole in the treatment of recurrent herpes labialis. J Infect Dis 1978; 137: 597-600
33. Constantopoulos A, Lagos P, Benetos S, et al. Disseminated neonatal herpes simplex infection treated with levamisole: report of a case. Dermatologica 1980; 160: 121-4
34. Smirnov IuK, Shishov AS, Bagrov FI, et al. Levamisole in the treatment of different forms of herpes zoster. Zh Nevropatol Psikhiatr Im S S Korsakova 1983; 83: 511-5
35. Parsad D, Pandhi R, Juneja A, et al. Cimetidine and levamisole versus cimetidine alone for recalcitrant warts in children. Pediatr Dermatol 2001; 18: 349-52
36. Parsad D, Saini R, Negi KS. Comparison of combination of cimetidine and levamisole with cimetidine alone in the treatment of recalcitrant warts. Australas J Dermatol 1999; 40: 93-5
37. Amer M, Tosson Z, Soliman A, et al. Verracae treated by levamisole. Int J Dermatol 1991; 30: 738-40
38. Saul A, Sanz R, Gomez M. Treatment of multiple viral warts with levamisole. Int J Dermatol 1980; 19: 342-3
39. Schou M, Helin P. Levamisole in a double-blind study: no effect on warts. Acta Derm Venereol 1977; 57: 449-54
40. Patrone F, Dallegri F, Bonvini E, et al. Disorders of neutrophil function in children with recurrent pyogenic infections. Med Microbiol Immunol (Berl) 1982; 171: 113-22
41. Businco L, Laurenti F, Rossi P, et al. A child with atopic features, raised serum IgE, and recurrent infection treated with levamisole. Arch Dis Child 1981; 56: 60-3
42. Verhaegen H, De Cree J, De Cock W, et al. Levamisole treatment of a child with severe aphthous stomatitis and neutropenia. Postgrad Med J 1976; 52: 511-4
43. Prakash MS, Rao VM, Reddy V. Effect of levamisole on the immune status of malnourished children. J Trop Pediatr 1998; 44: 165-6
44. Ellegaard J, Boesen AM. Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy: levamisole therapy for cellular immunologic deficiency with high IgE values. Scand J Haematol 1976; 17: 36-43
45. Sharma L, Thalliath GH, Girgia HS, et al. A comparative evaluation of levamisole in leprosy. Indian J Lepr 1985; 57: 11-6
46. Bera DK, Sen PC. Effect of levamisole on bacterial index in BL and LL leprosy. Int J Lepr Other Mycobact Dis 1985; 53: 198-200
47. Arora SK, Singh G, Sen PC. Immuno-stimulatory effect of levamisole in borderline leprosy cases. Indian J Lepr 1985; 57: 22-6
48. Haneke E. Levamisole treatment of acne fulminans. Z Hautkr 1981; 56: 1160-6
49. Lu SY, Chen WJ, Eng HL. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 438-45
50. Lozada F, Silverman S, Cram D. Pemphigus vulgaris: a study of six cases treated with levamisole and prednisone. Oral Surg Oral Med Oral Pathol 1982; 54: 161-5
51. Mashkilleson NA. Exacerbation of the course of pemphigus vulgaris after taking levamisole. Vestn Dermatol Venerol 1980; Oct (10): 46-8
52. Brzezinska-Wcislo L, Krauze E, Suwala-Jurczyk B. Levamisole in the treatment of crural ulcers. Przegl Dermatol 1990; 77: 51-5
53. Jautova J, Jarcuskova D, Dubivska M, et al. Immunostimulation therapy in patients with alopecia areata. Bratisl Lek Listy 1995; 96: 160-4
54. de Metieux P, Spitler LE, Paulus HE. Treatment of Behcet syndrome with levamisole. Arthritis Rheum 1981; 24: 64-70
55. Pachor ML, Bambara LM, Lunardi C, et al. Behcet's syndrome: description of a clinical case. Minerva Med 1982; 73: 3411-6
56. Lozada-Nur F, Cram D, Gorsky M. Clinical response to levamisole in thirty-nine patients with erythema multiforme: an open prospective study. Oral Surg Oral Med Oral Pathol 1992; 74: 294-8
57. Lozada-Nur F, Gorsky M, Silverman Jr S. Oral erythema multiforme: clinical observations and treatment of 95 patients. Oral Surg Oral Med Oral Pathol 1989; 67: 36-40
58. Lozada F. Levamisole in the treatment of erythema multiforme: a double-blind trial in fourteen patients. Oral Surg Oral Med Oral Pathol 1982; 53: 28-31
59. Scherak O, Smolen J, Kolarz G, et al. Clinical experience with levamisole treatment of patients with systemic lupus erythematosus. Wien Klin Wochenschr 1979; 91: 758-62
60. Tay C. Eosinophilic arthritis. Rheumatology (Oxford) 1999; 38: 1188-94
61. Runge LA, Pinals RS, Tomar RH. Treatment of rheumatoid arthritis with levamisole: long-term results and immune changes. Ann Rheum Dis 1979; 38: 122-7
62. Rondier J, Cayla J, Tron F, et al. Controlled trial of levamisole in rheumatoid arthritis: clinical and immunological study of 22 cases. Nouv Presse Med 1978; 7: 3023-7, 3029-30
63. Basch CM, Spitler LE, Engleman EG, et al. Cellular immune reactivity in patients with rheumatoid arthritis and effects of levamisole. J Rheumatol 1977; 4: 377-88
64. Huskisson EC, Scott J, Balme HW, et al. Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet 1976; I: 393-5
65. Veys EM, Mielants H, Verbruggen G. Goldsalts, levamisole and D-penidllamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis: a long-term follow-up study. Clin Exp Rheumatol 1987; 5: 111-6
66. Lu SY, Chen WJ, Eng HL. Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus: a 6-year prospective follow-up study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 705-9
67. Pasricha JS, Khera V. Effect of prolonged treatment with levamisole on vitiligo with limited and slow-spreading disease. Int J Dermatol 1994; 33: 584-7
68. Sanchez MR. Miscellaneous treatments: thalidomide, potassium iodide, levamisole, clofazimine, colchicine, and D-penicillamine. Clin Dermatol 2000; 18: 131-45
69. Medvedev IuA, Alekhin EK, Leshchenko VM. Use of immunostimulants in the treatment of a zooanthroponotic trichophyton infection. Vestn Dermatol Venerol 1987; 11: 70-3
70. Butler PG. Levamisole and immune response phenomena in cutaneous leishmaniasis. J Am Acad Dermatol 1982; 6: 1070-7
71. Makled M, Rifaat M, Azab M, et al. Determination of healing response by immunostimulant therapy (levamisole) in cutaneous leishmaniasis. Chemioterapia 1987; 6 (2 Suppl.): 214-6
72. Chong H. Oriental sore: a look at trends in and approaches to the treatment of leishmaniasis. Int J Dermatol 1986; 25: 615-23
73. Mukovozova LA. Effect of levamisole on the cellular and humoral immunity indices in patients with chronic brucellosis. Zh Mikrobiol Epidemiol Immunobiol 1988; 10: 45-9
74. Mukovozova LA. Effect of levamisole on the cellular immunity indices of patients with active forms of brucellosis. Zh Mikrobiol Epidemiol Immunobiol 1988; 6: 61-5
75. Thornes RD. Chronic human brucellosis and anti-anergic treatment with levamisole. Vet Rec 1977; 101: 27-30
76. Katzung BG. Basic and clinical pharmacology. 8th ed. Norwalk (CT): Lange Medical Books/McGraw Hill, 2001
77. National Center for Infectious Diseases. Infectious disease index [online]. Available from URL: http://www.cdc.gov/ncidod/index.htm [Accessed 2003 Mar 26]
78. Dale MM, Foreman JC, editors. Textbook of immunopharmacology. London: Blackwell Scientific Publications, 1984: 333-9
79. Seidlin M, Straus SE. Treatment of mucocutaneous herpes simplex infection. Clin Dermatol 1984; 2: 100-16
80. Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent-infection (Job's) syndrome: a review of the NIH experience and the literature. Medicine 1983; 62: 195-208
81. Vanheule R, De Cree J, Adriaenssens K, et al. Levamisole therapy for cellular immunologic deficiency with high IgE values. Acta Paediatr BeIg 1976; 29: 41-6
82. McManus AT. Examination of neutrophil function in a rat model of decreased host resistance following bum trauma. Rev Infect Dis 1983; 5 Suppl. 5: S898-907
83. Stinnett JD, Loose LD, Miskell P, et al. Synthetic immunomodulators for prevention of fatal infections in burned guinea pig model. Ann Surg 1983; 198: 53-7
84. Matachin EN, Atiasov NI, Zuev PD, et al. Methods of correction of humoral and cellular immunity in patients with bums and erosive-ulcerative lesions of the gastrointestinal tract. Vestn Khir Im II Grek 1990; 144: 44-9
85. Katoch K. Immunotherapy of leprosy. Indian J Lepr 1996; 68: 349-61
86. Martinez D, Zaias N. Levamisole as adjunct to dapsone in leprosy. Lancet 1976; II: 209-10
87. Carli-Basset C, Renoux M, Pauley AM, et al. Correlation between the immune reaction and clinical course in a bullous pemphigoid case treated with levamisole. LARC Med 1982; 2 (5): 400-41
88. Liapon AO, Rutshtein LG, Roitburd MF, et al. Levamisole (decaris) in the complex treatment of different clinical forms of psoriasis. Vestn Dermatol Venerol 1984; 4: 61-6
89. Sehgal VN, Jain S, Kumar S, et al. Generalized lichen nitidus in a child's response to cetirizine dihydrochloride/levamisol [letter]. Australas J Dermatol 1998; 39: 60
90. Boyd AS. New and emerging therapies for lichenoid dermatoses. Dermatol Clin 2000; 18: 21-9
91. Lavery HA, Pinkerton JH. Successful treatment of Behcet's syndrome with levamisole. Br J Dermatol 1985; 113: 372-3
92. Bang D. Treatment of Behcet's disease. Yonsei Med J 1997; 38: 401-10
93. Borrego LC, Escobar AS, Averhoff Casamayor MC, et al. Behcet's syndrome: report of the first case in Cuba. Rev Cubana Estomatol 1989; 26: 175-80
94. Wechsler B, Le Thi Huong DU, Godeau P. Medical treatment of Behcet's disease. J Mal Vase 1988; 13: 262-9
95. Dhar S, Kanwar AJ, Ghosh S. Levamisole in erythema multiforme. Oral Surg Oral Med Oral Pathol 1993; 76: 678-9
96. Ogawa K, Sano T, Hisano G, et al. Levamisole in systemic lupus erythematosus. Ann Allergy 1979; 43: 187-9
97. Smolen J, Scherak O, Menzel J, et al. Levamisole in systemic lupus erythematosus. Arthritis Rheum 1977; 20: 1558-9
98. Karchova TIu, Demin AA. The present-day treatment of systemic lupus erythematosus. Revmatologiia (Mosk) 1989; 4: 59-66
99. Veys EM, Mielants H, Verbruggen G, et al. Levamisole as basic treatment of rheumatoid arthritis: long-term evaluation. J Rheumatol 1981; 8: 45-6
100. Mowat AG. Levamisole and cellular immunity in rheumatoid arthritis: a review. J Rheumatol Suppl 1978; 4: 55-61
101. Yunus MB. Investigational therapy in rheumatoid arthritis: a critical review. Semin Arthritis Rheum 1988; 17: 163-84
102. Balabanova RM, Barakat B. Immunomodulating therapy of rheumatoid arthritis. Revmatologiia (Mosk) 1990; 3: 38-44
103. Hemandez-Perez E. Levamisole plus indomethacin in the treatment of herpes simplex. Dermatologica 1980; 160 (2): 118-20
104. Tanphaichitra D, Srimuang S. Efficacy of acyclovir combined with immunopotentiating agents in the treatment of varicella-zoster. J Antimicrob Chemother 1987; 19: 255-62
105. Glick M, Muzyka BC. Alternative therapies for major aphthous ulcers in AIDS patients. J Am Dent Assoc 1992; 123: 61-5
106. Wiggington JM. Reversal of ferritin mediated immunosuppression by levamisole: a rationale for its application to the management of the acquired immune deficiency syndrome (AIDS). Med Hypotheses 1995; 44: 85-8
107. Bourinbaiar AS, Lee-Huang S, Krasinski K, et al. Anti-HIV effect of immunomodulating agent, levamisole, in vitro. Biomed Pharmacother 1994; 48: 327-30
108. White CR, Hanifin JM. Levamisole therapy in atopic dermatitis: Randomized double-blind evaluation. Arch Dermatol 1978; 114: 1314-5
109. Sachar DB, Rubin KP, Gumaste V. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial. Am J Gastroenterol 1987; 82: 536-9
110. Dickler MN, Coit DG, Meyers ML. Adjuvant therapy of malignant melanoma. Surg Oncol Clin N Am 1997; 6: 793-812
111. Sondak VK, Wolfe JA. Adjuvant therapy for melanoma. Curr Opin Oncol 1997; 9: 189-204
112. Spitler LE. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma. J Clin Oncol 1991; 9: 736-40
113. Loutfi A, Shakr A, Jerry M, et al. Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma. Clin Invest Med 1987; 10: 325-8
114. Quirt IC, Shelley WE, Pater JL, et al. Improved survival in patients with poorprognosis malignant melanoma treated with adjuvant levamisole: a phase IH study by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1991; 9: 729-35
115. Barth A, Morton DL. The role of adjuvant therapy in melanoma management. Cancer 1995; 75 (2 Suppl.): 726-34
116. Wanebo HJ, Hilal EY, Pinsky CM, et al. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report. Cancer Treat Rep 1978; 62: 1663-9
117. Olivari AJ, Glait HM, Guardo A, et al. Levamisole in squamous cell carcinoma of the head and neck. Cancer Treat Rep 1979; 63: 983-90
118. Hazen PG, Kallor A, Michel B. Effects of levamisole in Sezary syndrome: apparent acceleration of disease. Dermatologica 1979; 159: 461-5
119. Arora SK, Singh G, Sen PC. Levamisole in cases of ENL. Indian J Lepr 1985; 57: 17-21
120. Singh NK, Jha TK, Singh IJ, et al. Combination therapy in Kala-azar. J Assoc Physicians India 1995; 43: 319-20
121. Veien NK. Cutaneous sarcoidosis: prognosis and treatment. Clin Dermatol 1986; 4: 75-87
122. Veien NK. Cutaneous sarcoidosis treated with levamisole. Dermatologica 1977; 154: 185-9
123. Cole PJ, Citron KM, Plowman PN, et al. The treatment of sarcoidosis by levamisole. Br J Dis Chest 1979; 73: 367-72
124. Folkers E, Tafelkruyer J. Subcomeal pustular dermatosis (Sneddon-Wilkinson disease): therapeutic problems. Br J Dermatol 1978; 98: 681-4